[The use of benzonal and saparal in the combined therapy of patients with acute inflammatory processes of the maxillofacial area].
The efficacy of inductors and adaptogens (benzonal and saparal) in combined therapy of patients with acute maxillofacial inflammations was investigated. These agents were conducive to shortening of the treatment periods and prevented complications (chronic osteomyelitis). A sooner recovery of the disordered homeostatic constants of the body (microsomal monoxygenase activities, acetylation processes, nonspecific resistance, leukocytic index of intoxication) was achieved.
Azimov
M I
MI
Krakovskiĭ
M E
ME
Ashirmerov
A Kh
AKh
D000038:Abscess / Q000628:therapy*; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use*; D002481:Cellulitis / Q000628:therapy*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005145:Face; D006801:Humans; D007571:Jaw Diseases / Q000628:therapy*; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D011182:Postoperative Care
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001463:Barbiturates; D010936:Plant Extracts; C057659:saparal; C002915:benzobarbital
Ispol'zovanie benzonala i saparala v kompleksnoĭ terapii bol'nykh s ostrymi vospalitel'nymi protsessami cheliustno-litsevoĭ oblasti.